Anavex Life Sciences Corp.宣布已成功开发出Anavex®3-71项目的每日一次口服片剂配方。这一重要进展标志着该公司在药物制剂技术方面取得了突破性成果,为Anavex®3-71项目的临床应用奠定了坚实基础。
Anavex Life Sciences Corp.宣布已成功开发出Anavex®3-71项目的每日一次口服片剂配方。这一重要进展标志着该公司在药物制剂技术方面取得了突破性成果,为Anavex®3-71项目的临床应用奠定了坚实基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.